IMMUCOTHEL (Biosyn/Kalgene)

N/A

Report date: 2024/12/11 10:05:05

Base Information

Drug NameIMMUCOTHEL (Biosyn/Kalgene)

Drug Alias NameIMMUCOTHEL

ClassificationVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsUrinary Bladder Neoplasms

Global Approved IndicationsUrinary Bladder Neoplasms

Approved Indications in ChinaN/A

Original Approved Country/TerritoryNetherlands

Original Approved Date1997/03/01

Country/TerritoryNetherlandsAustriaSouth Korea

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesBiosyn Corp

China Registration ClassN/A

Active CompaniesBiosyn Corp

Inactive CompaniesN/A

Active IndicationsUrinary Bladder Neoplasms

Inactive IndicationsN/A

ATC CodeJ07X